People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Edenbridge Holdings LLC | — | Pharmaceuticals | Series B | $15.4M | $523.9M | 2017 |
M. Ryan S. Collins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside M. Ryan S. Collins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Geoffrey S. Raker | 1 | 6 |
| JAMES S. HOCH | 1 | 5 |
| Frank S. Sica | 1 | 1 |
| Kevin S. Connelly | 1 | 1 |
| Kamal S. Maruf | 1 | 1 |
| Joseph S. Leary | 1 | 1 |
| Patrick S. Chu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.